TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.

M Agulnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.